Close
28/05/2015
Synchrotron light applications for the pharmaceutical industry
More than forty people from the pharmaceutical sector attended the workshop organised by the ALBA Synchrotron on May 7.

Researchers from the MSPD, CLAESS, XALOC, NCD and MISTRAL ALBA beam lines have shown the available state-of-the-art techniques and the advantages that they offer in this field: fast data acquisition and shorter experiments, cost savings and, in the case of X-ray microscopy, suppression of ethical conflicts because this technique can be a previous step before clinical essays with animals and persons.

The companies Enantia and Almirall, which have already collaborated with the ALBA Synchrotron, have commented their own experiences at the facility. Enantia, specialised in research solutions for other companies, has detailed different examples. For Almirall, the analysis of polymorphic compounds – performed at ALBA – has increased its quality control, verifying and quantifying purity grades.

News based on the press release issued by the ALBA synchrotron.

Image: ALBA synchrotron. Structure of a herpesvirus nuclease-antiviral complex. Data collected at the Xaloc beam line (Bongarzone, S., Nadal, M. & Coll, M., IBMB)

More news

29/09/2016 ​Barcelona, a Friendly Ecosystem for Start-Ups 22/09/2016 Barcelona, capital of particle accelerators science and technology 15/09/2016 Tech Companies With More Than $1 Million Raised: Barcelona Ranks 5th In Europe 09/09/2016 ​UB and UAB Universities Stand out in Spain According to Main International Rankings 31/08/2016 New CaixaBank's Data Center Implementation Completed In Barcelona Synchrotron Park 25/08/2016 ​Barcelona, 4th most creative city in the world
22 23 24 25 26 27 28 29 30 31 32